Bibliografía Detección Temprana de Alteraciones Visuales y Patologías Oculares

1 Wor1d Health Organization. Global Initiative for the Elimination of Avoidable Blindness, 2004; Fact Sheet 282. en : www.who.int/mediacentre/factsheets/fs282/en/ indexl
2 Ministerio de la Protección Social. Resolución número 2012 del 2004. Bogotá, Colombia. En: https://www.minproteccionsocial.gov.co
3 Johnson CA. Evaluation of Visual Function. Chapter 17, Foundation Volume 2, en Tasman W, Jaeger EA Duane‘s Ophthalmology 2000. Phyladelphia. Lippincott Williams & Wilkins 2000 CD-ROM Edition.
4 American Academy of Ophthalmology. Comprehesive Adult Medical Eye Evaluation, Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology, 2000. https://www.aao.org/aao/education/library/ppp/index.cfm
5 American Academy of Ophthalmology. Pediatric Eye Evaluations, Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology, 2002. En: http:/ /www.aao.org/aao/education/library/ppp/index.cfm
6 Stout AU, Wright KN. Pediatric Eye examination. Chapter 3 en: Wright KN, et al. Pediatric Ophthalmology and Strabismus 1st Ed, St Louis, MO Mosby 1995.
7 Wrigth KN. Visual Development, Amblyopia, and Sensory Adaptations. Chapter 9. En: Wright KN, et al. Pediatric Ophthalmology and Strabismus / 1st Ed, St Louis, MO Mosby 1995.
8 Moore A. Refraction and refractive errors. Chapter 8, en: Taylor D Pediatric Ophthalmology, 1st Ed, Oxford, Blackwell Scientific Publications, Inc 1990.
9 Kwon, YH, Caprioli J. Primary Open-Angle Glaucoma. Chapter 52 Clinical Volume 3, en Tasman W, Jaeger EA Duane‘s Ophthalmology 2000. Phyladelphia. Lippincott Williams & Wilkins 2000 CD-ROM Edition.
10 Benson WE. Diabetic Retinopathy. Chapter 30. Clinical Volume 3, en Tasman W, Jaeger EA Duane‘s Ophthalmology 2000. Phyladelphia. Lippincott Williams & Wilkins 2000 CD-ROM Edition.
11 Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985. 103: 1796-806.
12 Cryotherapy for Retinopathy of Prematurity Cooperative Group 15-Year Outcomes Following Threshold Retinopathy of Prematurity. Final Results From the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity. Arch Ophthalmol. 2005. 123: 311-318.
13 Ministerio de Salud, Programa de Apoyo a la Reforma de Salud (PARS), Universidad de Antioquia, Facultad Nacional de Salud Pública 2002, Modelo de oferta y demanda de recurso humano en salud en Colombia.
14 Asociación Colombiana de Facultades de Medicina, ASCOFAME, 2000. Recurso humano en medicina: formación, distribución y bases para una propuesta política. pisponible en: https://ascofame.org.co/publicaciones/
15 Ministerio de la Protección Social, Dirección General de Calidad, Base de datos de prestadores de servicios de salud, con base en el sistema único de habilitación. Consulta base de datos actualizada a marzo de 2006.
16 Thylefors B, Négrel A. D, Pararajasegara R, Dadzie K.Y. Global data on blindness. Bull Wold Healt Organ 1995. 73 (1): 115-21.
17 DANE. Estadísticas: Colombia, población y tasas de crecimiento media anual, según departamentos. 1999 y 1995-2015, tomada el 18 de agosto de 2005 en: www.dane.gov.co/infest/población/proyecciones/proyecc5.xl
18 World Health Organization Visión 2020 el derecho a ver Programa nacional de salud ocular para la prevención de la ceguera evitable. 2003.
19 World Health Organization International Classification of disease, 10th Edition (ICD-10).
20 Pendergrass TW, Davis S. Incidence of retinoblastoma in the United States. Arch Ophthalmol, 1980. 98: 1204-10.
21 Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984. 102: 520-6.
22 Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984. 102: 527-32.
23 Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003. Jan. 121 (1): 48-56.
24 Sperduto RD. Epidemiologic Aspects Of Age Related Cataract. Chapter 73A, Clinical Volume 1, en Tasman W, Jaeger EA Duane‘s Ophthalmology 2000. Phyladelphia. Lippincott Williams & Wilkins, 2000, CD-ROM Edition.
25 Clare G, Allen F. Childhood blindness in the context of Vision 2020, The Right to Sight. Bulletin of the World Health Organization, 2001. 79: 227–232.
26 Rahi JS, Dezateux C. National cross sectional study of detection of congenital and infantile cataract in the United Kingdom: role of childhood screening and surveillance. The British Congenital Cataract Interest Group. BMJ. 1999. Feb 6; 318 (7180): 362-5.
27 Simons K RR. Amblyopia screening and stereopsis. In: Helveston EM, ed. Symposium on Strabismus: Transactions of the New Orleans Academy of Ophthalmology. St Louis: CV Mosby Co., 1978.
28 Screening for visual impairment in children younger than age 5 years: recommendation statement. Ann Fam Med 2004. 2 (3): 263-6.
29 Community Paediatrics Committee, Canadian Paediatric Society. Vision screening in infants, children and youth. Paediatrics and Child Health 1998. 3 (4): 261- 262 en: https://www.cps.ca/english/statements/CP/cp98-01.
30 Ministerio de la Protección Social. Resolución Número 1043 de 2006. Bogotá, Colombia. En: https://www.minproteccionsocial.gov.co
31 Wrigth KN. Introduction to Strabismus and the Ocular-Motor Examination. Chapter 10. En: Wright KN, et al. Pediatric Ophthalmology and Strabismus / 1st Ed, St Louis, MO Mosby, 1995.
32 American Academy of Ophthalmology. Refractive Errors, Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology, 2002. 53p, en: http:/ /www.guideline.gov/summary/summary.aspx?ss=14&doc_id=3545&string
33 American Optometric Association. Care of the patient with presbyopia. 2nd ed. St. Louis (MO): American Optometric Association; 1998. 61 p. (Optometric clinical practice guideline; No. 17), disponible en: https://www.aoa.org/x815.xml
34 Cryotherapy for Retinopathy of Prematurity Cooperative Group Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988. 106: 471-479.
35 Cryotherapy for Retinopathy of Prematurity Cooperative Group Multicenter trial of cryotherapy for retinopathy of prematurity. 3 ½ year outcome structure and function. Arch Ophthalmol 1993. 111: 339-344.
36 McNamara JA, Tasman W , Brown GC, Federman JL Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmo1ogy 1991. 98: 576-580.
37 Hunter DG, Repka MX Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study. Ophthalmology 1993. 100: 238-244.
38 Banac MJ, Berinstein DM. Laser therapy for retinopathy of prematurity. Curr Opin Ophthalmol 2001. 12: 164–170.
39 International Committee for the Classification of Retinopathy of Prematurity The International. Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005. Jul. 123 (7): 991-9.
40 Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003, Jan. 121 (1): 48-56.